| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 5 | 2018 | 131 | 1.460 |
Why?
|
| Reactive Oxygen Species | 5 | 2018 | 480 | 1.290 |
Why?
|
| Histone Demethylases | 5 | 2018 | 30 | 1.200 |
Why?
|
| Hepatocyte Growth Factor | 5 | 2014 | 84 | 0.760 |
Why?
|
| Erythrocytes | 2 | 2018 | 255 | 0.700 |
Why?
|
| Proto-Oncogene Proteins c-met | 9 | 2009 | 199 | 0.700 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.640 |
Why?
|
| Hemoglobin, Sickle | 1 | 2017 | 19 | 0.630 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 182 | 0.540 |
Why?
|
| Fetal Hemoglobin | 4 | 2018 | 14 | 0.480 |
Why?
|
| Mitochondria | 1 | 2017 | 535 | 0.460 |
Why?
|
| Enzyme Inhibitors | 4 | 2018 | 639 | 0.400 |
Why?
|
| Lung Neoplasms | 7 | 2008 | 2262 | 0.390 |
Why?
|
| Intestinal Mucosa | 5 | 2015 | 797 | 0.350 |
Why?
|
| gamma-Globins | 3 | 2018 | 5 | 0.340 |
Why?
|
| Paxillin | 2 | 2008 | 59 | 0.330 |
Why?
|
| Indoles | 6 | 2009 | 318 | 0.330 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 153 | 0.280 |
Why?
|
| Piperazines | 5 | 2009 | 272 | 0.270 |
Why?
|
| Sulfonamides | 5 | 2009 | 300 | 0.260 |
Why?
|
| Pleural Neoplasms | 1 | 2006 | 188 | 0.240 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2007 | 1075 | 0.230 |
Why?
|
| Mesothelioma | 1 | 2006 | 311 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 301 | 0.210 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2014 | 78 | 0.210 |
Why?
|
| Reticulocytes | 3 | 2018 | 25 | 0.210 |
Why?
|
| Disease Models, Animal | 6 | 2018 | 2232 | 0.200 |
Why?
|
| Quercetin | 1 | 2000 | 3 | 0.190 |
Why?
|
| Animals | 18 | 2018 | 26582 | 0.190 |
Why?
|
| Carotenoids | 1 | 2000 | 14 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 1 | 2000 | 40 | 0.190 |
Why?
|
| Anticarcinogenic Agents | 1 | 2000 | 70 | 0.180 |
Why?
|
| RNA, Small Interfering | 6 | 2009 | 547 | 0.180 |
Why?
|
| Mice | 10 | 2018 | 11352 | 0.170 |
Why?
|
| Cell Line, Tumor | 8 | 2011 | 2426 | 0.170 |
Why?
|
| Receptors, Growth Factor | 2 | 2009 | 52 | 0.170 |
Why?
|
| Tretinoin | 2 | 2015 | 126 | 0.160 |
Why?
|
| Hemolysis | 1 | 2017 | 61 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2012 | 645 | 0.150 |
Why?
|
| Rhodamines | 1 | 2017 | 18 | 0.150 |
Why?
|
| Spiro Compounds | 1 | 2017 | 25 | 0.150 |
Why?
|
| Papio | 4 | 2018 | 82 | 0.150 |
Why?
|
| Thiophenes | 1 | 2017 | 48 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 2 | 2007 | 134 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2017 | 420 | 0.140 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2015 | 5 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 2 | 2008 | 552 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2015 | 6 | 0.140 |
Why?
|
| Sirolimus | 1 | 2017 | 169 | 0.140 |
Why?
|
| Humans | 24 | 2018 | 86643 | 0.130 |
Why?
|
| Tranylcypromine | 1 | 2015 | 1 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 83 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2009 | 3241 | 0.120 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 30 | 0.120 |
Why?
|
| Immunohistochemistry | 7 | 2013 | 1753 | 0.120 |
Why?
|
| Mutation | 7 | 2011 | 3968 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 589 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2015 | 1106 | 0.110 |
Why?
|
| Neuraminidase | 1 | 2013 | 45 | 0.110 |
Why?
|
| Milk, Human | 1 | 2013 | 43 | 0.110 |
Why?
|
| Smad7 Protein | 1 | 2012 | 7 | 0.110 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2012 | 15 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2012 | 18 | 0.110 |
Why?
|
| Cell Movement | 2 | 2007 | 758 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 139 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 166 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2009 | 207 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2013 | 782 | 0.090 |
Why?
|
| RNA Interference | 2 | 2008 | 369 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1749 | 0.090 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 83 | 0.090 |
Why?
|
| Colon | 1 | 2012 | 496 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 24 | 0.080 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2008 | 21 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 554 | 0.080 |
Why?
|
| Vulva | 1 | 2008 | 23 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 879 | 0.080 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 16 | 0.080 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 78 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 532 | 0.080 |
Why?
|
| Blood Cell Count | 2 | 2018 | 79 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 307 | 0.080 |
Why?
|
| Thiocarbamates | 1 | 2007 | 6 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2008 | 1197 | 0.080 |
Why?
|
| Muridae | 1 | 2007 | 8 | 0.080 |
Why?
|
| Spindle Apparatus | 2 | 2004 | 65 | 0.080 |
Why?
|
| Mitosis | 2 | 2004 | 153 | 0.080 |
Why?
|
| Cell Survival | 2 | 2007 | 969 | 0.080 |
Why?
|
| Sulfones | 1 | 2007 | 43 | 0.080 |
Why?
|
| Apoptosis | 1 | 2013 | 1683 | 0.070 |
Why?
|
| Proline | 1 | 2007 | 57 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 696 | 0.070 |
Why?
|
| Cell Nucleus | 4 | 2013 | 579 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 133 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 3030 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 104 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 189 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 223 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 158 | 0.070 |
Why?
|
| Anemia | 2 | 2018 | 128 | 0.070 |
Why?
|
| Sodium Selenite | 1 | 2005 | 2 | 0.070 |
Why?
|
| Diethylnitrosamine | 1 | 2005 | 7 | 0.070 |
Why?
|
| Phenobarbital | 1 | 2005 | 33 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 68 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 27 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 74 | 0.070 |
Why?
|
| Polyamines | 1 | 2005 | 32 | 0.070 |
Why?
|
| Antioxidants | 1 | 2007 | 223 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 119 | 0.070 |
Why?
|
| Cell Division | 1 | 2007 | 696 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1961 | 0.070 |
Why?
|
| Base Sequence | 2 | 2007 | 2330 | 0.070 |
Why?
|
| Neoplasms | 2 | 2011 | 2898 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 736 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2006 | 692 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 322 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 1041 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2004 | 144 | 0.060 |
Why?
|
| Microtubules | 1 | 2004 | 119 | 0.060 |
Why?
|
| Transfection | 3 | 2012 | 896 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1920 | 0.060 |
Why?
|
| Histones | 2 | 2016 | 311 | 0.060 |
Why?
|
| Cisplatin | 2 | 2009 | 612 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2011 | 790 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 176 | 0.060 |
Why?
|
| Protein Isoforms | 3 | 2013 | 270 | 0.060 |
Why?
|
| Melanoma | 1 | 2007 | 459 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 546 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 376 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 1076 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1578 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2013 | 510 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 1052 | 0.050 |
Why?
|
| Premature Birth | 2 | 2013 | 113 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2004 | 1196 | 0.050 |
Why?
|
| Vitamin A | 1 | 2000 | 27 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 68 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 1230 | 0.050 |
Why?
|
| Drug Design | 1 | 2018 | 124 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 927 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 1721 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 684 | 0.040 |
Why?
|
| Gene Expression | 2 | 2013 | 1284 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2009 | 458 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 2360 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 266 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 39 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 2 | 2008 | 353 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2015 | 52 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6509 | 0.030 |
Why?
|
| Hydroxyurea | 1 | 2015 | 239 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 180 | 0.030 |
Why?
|
| Tubulin | 2 | 2004 | 58 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 251 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 20 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2013 | 34 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 17 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 48 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2013 | 49 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 26 | 0.030 |
Why?
|
| Plasmids | 2 | 2004 | 287 | 0.030 |
Why?
|
| Rats | 2 | 2014 | 3990 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2004 | 393 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 121 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 125 | 0.030 |
Why?
|
| Term Birth | 1 | 2013 | 8 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 307 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2004 | 498 | 0.030 |
Why?
|
| Papio cynocephalus | 1 | 2012 | 3 | 0.030 |
Why?
|
| Papio anubis | 1 | 2012 | 7 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 292 | 0.030 |
Why?
|
| Lactation | 1 | 2013 | 53 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2014 | 128 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 543 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 371 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 214 | 0.030 |
Why?
|
| Denaturing Gradient Gel Electrophoresis | 1 | 2012 | 1 | 0.030 |
Why?
|
| Chemokine CXCL5 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.030 |
Why?
|
| Aged | 2 | 2008 | 18415 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1981 | 0.030 |
Why?
|
| Swine | 1 | 2013 | 555 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 38 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 28 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 2062 | 0.030 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2011 | 13 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1718 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 679 | 0.030 |
Why?
|
| Gestational Age | 1 | 2012 | 311 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 79 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2016 | 628 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1540 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 504 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1219 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 236 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 281 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 2261 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 25028 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 989 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 379 | 0.020 |
Why?
|
| Female | 4 | 2018 | 44532 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 411 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 290 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 2378 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 776 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 444 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 669 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 615 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2818 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2468 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 181 | 0.020 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 21 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 691 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2007 | 14 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3046 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2894 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 316 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 920 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1208 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 689 | 0.020 |
Why?
|
| Stem Cells | 1 | 2008 | 351 | 0.020 |
Why?
|
| Nicotine | 1 | 2008 | 194 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2379 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2009 | 485 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 223 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 712 | 0.020 |
Why?
|
| Male | 4 | 2011 | 40965 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 45 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 407 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2005 | 297 | 0.020 |
Why?
|
| Interphase | 1 | 2004 | 34 | 0.020 |
Why?
|
| Organ Size | 1 | 2005 | 364 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 68 | 0.020 |
Why?
|
| Dynactin Complex | 1 | 2004 | 2 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 268 | 0.020 |
Why?
|
| Dyneins | 1 | 2004 | 14 | 0.020 |
Why?
|
| Gene Library | 1 | 2004 | 130 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 2004 | 108 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2005 | 172 | 0.020 |
Why?
|
| Body Weight | 1 | 2005 | 459 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 111 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 5210 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1805 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 193 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 425 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 557 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 502 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1014 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5417 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 1458 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 2438 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 25648 | 0.010 |
Why?
|